Argenx (ARGX) is a publicly traded Healthcare sector company. As of August 19, 2026, ARGX trades at $977.70 with a market cap of $61.80B and a P/E ratio of 0.00. ARGX moved +0.60% today. Year to date, ARGX is +18.08%; over the trailing twelve months it is +50.15%. Its 52-week range spans $510.06 to $1,009.74. Analyst consensus is strong buy with an average price target of $1,076.16. Rallies surfaces ARGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ARGX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $977.70 |
| Market Cap | $61.80B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,009.74 |
| 52-Week Low | $510.06 |
| Volume | 311.82K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
21 analysts cover ARGX: 0 strong buy, 19 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,076.16.